The Villages Health's $538M Medicare Settlement Anchors Liquidating Plan
The Villages Health's chapter 11 turned on a Medicare coding program that made the U.S. its largest creditor. After selling its primary care centers to CenterWell for $68M, the provider settled the government claim at $538.3M and reached an $80M developer settlement to fund a liquidating plan.
The Villages Health System, LLC has agreed to a $538.3 million allowed claim for the United States and to accept an $80 million contribution from the Morse-family developer that controls the nation's largest retirement community—twin settlements that now anchor the senior-care provider's chapter 11 plan of liquidation. The company filed for chapter 11 on July 3, 2025 in the U.S. Bankruptcy Court for the Middle District of Florida (Case No. 25-04156, Hon. Lori V. Vaughan), after disclosing that a retrospective Medicare coding program had generated at least $350 million in overpayments.
TVH operated eight primary care centers and two specialty care centers serving more than 55,000 patients—most of them enrolled in Medicare Advantage plans—in The Villages, the central Florida retirement community developed by the Morse family. The internal investigation that triggered the filing made the federal government the largest creditor by a wide margin and steered the case toward a rapid sale rather than a standalone reorganization. The debtors entered bankruptcy with a $50 million stalking horse agreement from CenterWell Senior Primary Care (Vitality), Inc., a subsidiary of Humana, and a 363 auction lifted the price to $68 million before the sale closed on November 7, 2025.
With its operating assets sold, the case has shifted into a liquidating chapter 11 built around resolving the federal claim and pursuing insider and payor causes of action through a liquidating trust. The court conditionally approved the disclosure statement on March 26, 2026, but the combined disclosure-statement and confirmation hearing—together with a trial on the two cornerstone settlements—was continued to July 8–9, 2026.
| Debtor(s) | The Villages Health System, LLC |
| Court | U.S. Bankruptcy Court, Middle District of Florida (Orlando Division) |
| Case Number | 25-04156 |
| Judge | Hon. Lori V. Vaughan |
| Petition Date | July 3, 2025 |
| DIP Facility | $39 million (PMA Lender LLC; $24M new money, $15M roll-up) |
| Sale Approval | September 9, 2025 — CenterWell, $68 million |
| Sale Closing | November 7, 2025 |
| Government Claim | ~$538.3 million (DOJ settlement) |
| Developer Settlement | $80 million (Morse-family developer) |
| Plan Status | Liquidating plan; combined confirmation/settlement hearing July 8–9, 2026 |
| Claims Agent | Stretto |
Open the public case profile for docket context, hearings, advisors, and plan updates.
Medicare Coding Investigation and the Government Claim
The Villages Health was formed in 2012 in collaboration with the University of South Florida to serve the elderly population of The Villages, a retirement community with more than 130,000 residents whose patient base is heavily dependent on Medicare and Medicare Advantage coverage. That payer concentration placed the accuracy of diagnostic coding at the center of the organization's finances, because Medicare Advantage plans pay insurers more for patients with more severe documented conditions under the risk-adjustment system.
Chief Restructuring Officer Neil Luria's first day declaration traced the filing to a retrospective chart review program, begun around 2020, that reviewed historical patient charts to identify diagnoses tied to Medicare Advantage reimbursement. The declaration states that TVH became aware of potential problems with its Hierarchical Condition Category coding in approximately August 2024. Legitimate risk-adjustment coding requires contemporaneous clinical documentation for each diagnosis; the review found that some submitted codes lacked sufficient clinical support and that some charts were amended after the 90-day CMS deadline for record modifications.
TVH initiated a voluntary self-disclosure to the Office of Inspector General in December 2024, was accepted into the OIG self-disclosure protocol on January 31, 2025, and by April 2025 had given OIG and the Department of Justice a preliminary overpayment analysis estimating at least $350 million in improper payments. The scale of that exposure—reported at $350 million or more based on inaccurately recorded patient diagnoses—made the United States the dominant creditor heading into the July 2025 filing.
The government's claim was fixed nine months later. Under the DOJ settlement filed March 20, 2026, TVH is deemed liable to the United States for an initial $541.5 million, subject to credits for funds CMS recovers from Medicare Advantage organizations. After $3.17 million in returns from Humana and Blue Cross Blue Shield of Florida, the United States' allowed claim was stated at $538,327,235.99 as of March 9, 2026—an undisputed, noncontingent, and nondischargeable claim that dwarfs every other obligation in the case.
The settlement releases civil and administrative monetary claims for the "Covered Conduct"—the HCC coding irregularities that produced improper Medicare payments—under the False Claims Act, the Civil Monetary Penalties Law, and common-law payment-by-mistake, unjust-enrichment, and fraud theories. HHS-OIG waives permissive exclusion for the Covered Conduct but reserves mandatory-exclusion rights, and the United States expressly preserves tax, criminal, and individual liability and any conduct beyond the Covered Conduct. TVH agreed not to pursue risk-adjustment payments withheld by Medicare Advantage organizations that settle with the government and may pursue non-settling organizations only after May 1, 2027.
Affiliate DIP Financing and Competing UnitedHealthcare Proposal
TVH entered bankruptcy owing a $15 million prepetition facility to PMA Lender LLC, and it returned to the same lender for postpetition financing. The DIP motion sought a $39 million facility comprising $24 million in new money and a $15 million roll-up of the prepetition loan, with PMA identified as an affiliate lender by virtue of common ownership or control. The facility carried a 12% fixed interest rate on new-money advances and waived standard upfront, origination, unused-line, exit, and agency fees, with $5 million of new money available on an interim basis and $19 million on final approval.
The original DIP package imposed an aggressive timeline, requiring a final DIP order by August 15, 2025, a sale order by September 1, a sale closing by October 3, and plan confirmation by January 30, 2026. The court entered an interim DIP order on July 11, 2025, eight days after the petition, authorizing the initial $5 million draw to fund payroll and patient care while the full facility moved through approval.
UnitedHealthcare challenged the affiliate financing. In its August 2025 DIP objection, the insurer said it had offered a competing $45.5 million DIP loan on August 3, 2025 and argued that the PMA facility improperly entrenched insider control, burdened valuable estate claims, and favored the affiliate lender over other creditors. The amended DIP ultimately governed, and a final DIP order entered November 20, 2025 confirmed that all DIP obligations had been paid in full and that the DIP liens and superpriority claims were released and extinguished following the sale.
CenterWell Stalking Horse and the 363 Sale
CenterWell had been in discussions with TVH well before the filing: the first day declaration states that CenterWell signed a term sheet in April 2024 and later agreed to serve as stalking horse bidder under a $50 million all-cash asset purchase agreement. CenterWell is the nation's largest senior-focused, value-based primary care provider, serving approximately 450,000 patients at 350 locations across 15 states, including 150 centers in Florida, and it committed to offer employment to substantially all of TVH's 800-plus employees.
The bidding procedures order was entered July 28, 2025 over an earlier UnitedHealthcare sale objection that argued the prepetition marketing process was not sufficiently competitive, the timeline was too compressed, and the requested bid protections were inadequately supported. A supplemental Evercore declaration confirmed that CenterWell submitted the successful bid of $68 million plus assumed liabilities on September 7, 2025.
The court entered the sale order on September 9, 2025, designating CenterWell the successful bidder, authorizing assumption and assignment of executory contracts, and making explicit good-faith and arm's-length findings under section 363(m). The final $68 million price represented an $18 million increase over the stalking horse bid. The sale closed on November 7, 2025, with substantially all of the debtor's assets and listed executory contracts and leases assigned to CenterWell. The estate has since wound down residual real estate, including a May 2026 motion to sell a single-family home at 11368 Laufersky Lane in Oxford, Florida for $310,000 free and clear of liens.
Payor Objections and Insider-Transfer Allegations
Commercial insurers used the bankruptcy to press their own overbilling claims. Florida Blue's cure objection, filed August 21, 2025, asserted approximately $25 million in overpayments tied to Medicare Advantage coding over payment years 2021 through 2024, alleging the use of unsupported diagnostic codes such as "Coagulation Defects and Other Specified Hematological Disorders" and "specified Heart Arrhythmias," with roughly $8 million of the total attributed to 2024 alone. The insurer also argued that the debtor's listed $0 cure amounts were incorrect and that the contracts would need to be identified and assumed in full.
UnitedHealthcare went further, warning of insider conflicts and using its DIP objection to spotlight roughly $183 million in transfers to insiders from 2022 through 2024—$64.2 million of related distributions and $118.8 million used to pay down a purported Morse-family line of credit. UnitedHealthcare framed those transfers as estate causes of action that should not be encumbered by an insider DIP.
By February 2026 the official committee of unsecured creditors had shifted from sale-process disputes to a post-sale investigation, issuing Rule 2004 examination notices to The Villages Health Holding Company, Mark Morse, Jennifer Morse Parr, Tracy Morse Dadeo, and physicians Dr. Jeffrey Lowenkron and Dr. Elliot Sussman. The notices target HCC coding, Medicare overbilling, self-disclosure materials, and insider transactions—the same conduct the liquidating plan later channeled into a trust.
Developer Settlement and the Liquidating Plan
The Morse-family developer settlement resolves the insider-transfer claims that UnitedHealthcare and the committee had pressed. Under the Developer settlement filed March 20, 2026, the Developer—The Villages Health Holding Company, PMA Lender LLC, and 20 named affiliates including The Villages of Lake-Sumter, Inc.—agreed to pay an aggregate $80 million, structured either as $80 million in cash after the debtor satisfies the $15 million PMA secured claim or as $80 million reduced by that claim with the balance paid in cash. The release covers the estate's settled claims, including potential recharacterization or avoidance of the TVHH and PMA lines of credit (net repayments of roughly $108 million), avoidance of about $69 million in tax-distribution payments, and avoidance of approximately $268 million in rent and service payments to the Developer and its affiliates.
Because the United States holds roughly 97% of unsecured claims, DOJ support is effectively determinative of confirmation, and the settlement motion conditions the deal on that support and relies on the CRO's independent fairness determination as a check on insider conflict. The developer publicly expressed optimistic support for the settlement shortly after it was filed. The settling parties are brought within the plan's "Released Parties" definition through mutual releases.
The first amended plan of liquidation, filed alongside the settlements, restructures creditor treatment into seven impaired classes and channels remaining estate assets into a liquidating trust with Neil Luria as liquidating trustee. The trust holds cash, insider claims, D&O claims, payor claims, and other retained causes of action for the benefit of trust beneficiaries, and a liquidation analysis was filed March 23, 2026 to support confirmation.
| Class | Claim / Interest | Status | Est. Recovery |
|---|---|---|---|
| 1 | Prepetition Secured Loan Claims | Impaired (vote) | 100% (cash) |
| 2 | Other Secured Claims | Impaired (vote) | 100% |
| 3 | Convenience Class Claims | Impaired (vote) | 90% |
| 4 | DOJ Claims and Payor Claims | Impaired (vote) | Undetermined |
| 5 | General Unsecured Claims | Impaired (vote) | Undetermined |
| 6 | Subordinated Section 510(b) Claims | Impaired | 0% |
| 7 | Equity Interests | Deemed to reject | 0% |
Class 1 holders receive cash equal to their allowed claims, and the DOJ treatment in Class 4 tracks the government settlement's $538.3 million allowed claim. The amended disclosure statement was conditionally approved on March 26, 2026, with a combined confirmation hearing initially set for June 2, 2026. On the debtor's motion, the court continued the combined hearing and settlement trial to July 8–9, 2026, extended the major-creditor objection deadline to July 1, and stayed discovery from May 15 through June 20, 2026.
Professional retentions and fees. The debtor retained Evercore Group L.L.C. as investment banker under a $600,000 upfront retainer, a $200,000 monthly fee, a $5 million restructuring fee, and a financing fee equal to 1.25% of gross proceeds. BakerHostetler, lead debtor's counsel, sought $2,538,266 in fees and $7,891.86 in expenses for July 3 through October 31, 2025 in its first interim application, and the court later approved interim compensation for BakerHostetler and Goodwin Procter along with fees for the patient care ombudsman. Stretto has served as claims and noticing agent since the petition date.
Post-Sale Network Transition
Because CenterWell is a Humana subsidiary, the ownership change raised questions about whether TVH locations would remain accessible to patients enrolled in non-Humana Medicare Advantage plans heading into the open-enrollment period. Negotiations with UnitedHealthcare continued through fall 2025, and some patients reported feeling "duped" by the uncertainty, with some switching Medicare plans during open enrollment to keep access to their physicians.
CenterWell ultimately reached a long-term agreement with UnitedHealthcare to keep TVH locations in network for UHC members in 2026. For 2026, TVH locations accept plans from Aetna, CarePlus, Florida Blue, Humana, and UnitedHealthcare, consistent with CenterWell's commitment to maintain a payor-agnostic structure.
Key Timeline
| Date | Event |
|---|---|
| 2012 | TVH formed in collaboration with the University of South Florida |
| ~2020 | Retrospective chart review program initiated |
| August 2024 | TVH becomes aware of potential HCC coding issues |
| December 2024 | TVH initiates OIG voluntary self-disclosure |
| January 31, 2025 | TVH accepted into OIG self-disclosure protocol |
| July 3, 2025 | Chapter 11 petition, first day declaration, DIP and sale motions filed |
| July 11, 2025 | Interim DIP order ($5M authorized) |
| July 21, 2025 | UnitedHealthcare files sale objection |
| July 28, 2025 | Bidding procedures order entered |
| August 21, 2025 | Florida Blue cure objection ($25M) |
| September 9, 2025 | Sale order approved ($68M to CenterWell) |
| November 7, 2025 | Sale closes |
| November 20, 2025 | Final DIP order; DIP obligations paid in full |
| January 29, 2026 | Plan of liquidation and disclosure statement filed |
| March 20, 2026 | DOJ settlement (~$538.3M), $80M Developer settlement, and amended plan filed |
| March 26, 2026 | Disclosure statement conditionally approved |
| May 8, 2026 | Motion to sell Laufersky Lane home for $310,000 |
| July 8–9, 2026 | Combined confirmation hearing and settlement trial (scheduled) |
Frequently Asked Questions
Why did The Villages Health System file for bankruptcy?
TVH filed after an internal investigation found that a retrospective chart review program begun around 2020 was inconsistent with Medicare guidelines, producing at least $350 million in estimated overpayments from inaccurately recorded diagnoses. The company discovered the issues in August 2024, self-disclosed to the OIG in December 2024, and filed chapter 11 in July 2025 with the United States as its largest creditor.
How large is the government's claim, and how was it resolved?
Under a settlement filed in March 2026, TVH is deemed liable to the United States for an initial $541.5 million, reduced to an allowed claim of $538,327,235.99 as of March 9, 2026 after Medicare Advantage organization returns. The claim is undisputed, noncontingent, and nondischargeable, and the release covers False Claims Act and Civil Monetary Penalties Law exposure for the coding conduct while preserving tax, criminal, and individual liability.
What is the $80 million Developer settlement?
The Morse-family developer and 20 named affiliates agreed to contribute $80 million to fund the plan in exchange for releases of estate claims, including roughly $268 million in alleged rent and service payments, about $108 million in line-of-credit repayments, and approximately $69 million in tax-distribution payments. The settlement resolves the insider-transfer theories that UnitedHealthcare and the creditors' committee had urged the estate to preserve.
Who acquired The Villages Health?
CenterWell Senior Primary Care (Vitality), Inc., a Humana subsidiary, acquired TVH's assets. CenterWell entered as a $50 million stalking horse bidder and ultimately paid $68 million following the auction, and it committed to offer employment to substantially all of TVH's 800-plus employees.
What does the liquidating plan provide for creditors?
The amended plan sorts claims into seven impaired classes and routes remaining assets into a liquidating trust led by Neil Luria. Secured Class 1 and Class 2 claims are slated for full cash recovery and convenience claims for 90%, while recoveries for the DOJ and payor claims (Class 4) and general unsecured claims (Class 5) are undetermined; subordinated and equity classes receive nothing.
What is the current status of the case?
The disclosure statement was conditionally approved on March 26, 2026, but the combined confirmation hearing and a trial on both settlements were continued to July 8–9, 2026, with major-creditor objection deadlines extended to July 1, 2026. No settlement approval or plan confirmation had been entered as of mid-2026.
Will patients keep their insurance coverage?
For 2026, TVH locations accept plans from Aetna, CarePlus, Florida Blue, Humana, and UnitedHealthcare. CenterWell reached a long-term agreement with UnitedHealthcare to maintain network access for UHC members and committed to keep TVH's payor-agnostic structure.
Related coverage. For other senior-care and hospital restructurings, see ElevenFlo's reporting on Senior Care Centers' Texas skilled-nursing chapter 11, LaVie Care Centers' path to emergence, and Center City Healthcare's liquidation and Hahnemann wind-down.
This article was researched and written with AI assistance, using court filings, public records, and news sources. AI-generated content can contain errors. Verify all information against primary sources before relying on it. This is not legal or financial advice. Read our full disclaimer.
Get briefings like this by email
New chapter 11 filings and key developments. Unsubscribe anytime.